“Evaluation of Ischemia Modified Albumin IMA as New Predictor in Patients with Newly Thyroid Dysfunction in Type 2 Diabetes Mellitus”, MLU, vol. 21, no. 2, pp. 1426–1431, Mar. 2021, doi: 10.37506/mlu.v21i2.2892.